Ruben Bonilla Guerrero | Chief Medical Officer
Innovative Gx Laboratories

Ruben Bonilla Guerrero, Chief Medical Officer, Innovative Gx Laboratories

Dr. Ruben Bonilla-Guerrero serves as Innovative Genomics (IGx) Laboratories’ Chief Medical Officer. He is a Mayo Clinic trained laboratory professional board certified in Clinical Biochemical Genetics by the American Board of Medical Genetics (ABMG) and in Molecular Biology by the American Society for Clinical Pathology (ASCP), with expertise in clinical pharmacology, inborn errors of metabolism, genetics, vaccine development, and clinical pharmacogenomics. Previously, Dr. Bonilla-Guerrero simultaneously served as Laboratory Director, Associate Medical Director, and Medical Director of Medical Affairs for the department of Genetics at Quest Diagnostics, as well as concurrently served as the Medical Director and Vice President of Medical Affairs at Admera Health. He is responsible for the clinical genomic-based testing at Innovative Gx Laboratories and leads the Medical Affairs team.

Dr. Ruben Bonilla-Guerrero serves as Innovative Genomics (IGx) Laboratories’ Chief Medical Officer. He is a laboratory professional, who is Mayo Clinic trained in Clinical Pharmacology, Clinical Biochemical Genetics, and Molecular Biology, a Fellow of the American College of Medical Genetics, the American Association of Clinical Chemistry, and is an active member of several distinguished professional organizations. Dr. Ruben Bonilla-Guerrero board certified in Clinical Biochemical Genetics by the American Board of Medical Genetics (ABMG) and in Molecular Biology by the American Society for Clinical Pathology (ASCP), with expertise in clinical pharmacology, inborn errors of metabolism, genetics, vaccine development, and clinical pharmacogenomics. Having authored several peer-reviewed medical publications including book chapters, Dr. Bonilla-Guerrero is also the winner of the Henry Christian Award from the American Federation for Medical Research (2002) and the Mayo Clinic Department of Internal Medicine Outstanding Research Fellow Award (2003). Previously, Dr. Bonilla-Guerrero simultaneously served as Laboratory Director, Associate Medical Director, and Medical Director of Medical Affairs for the department of Genetics at Quest Diagnostics, as well as concurrently served as the Medical Director and Vice President of Medical Affairs at Admera Health. He is responsible for the clinical genomic-based testing at Innovative Gx Laboratories and leads the Medical Affairs team.

Appearances:



World Drug Safety Congress Americas 2022 Day 2 @ 14:45

Translating genomics into improved patient outcomes

last published: 01/Oct/22 14:05 GMT

back to speakers

Get Involved At Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Semen Sen
Semen.sen@terrapinn.com
t/ +1 646 619 1793

 

 

To Speak


Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

Marketing & Press Opportunities


Taylor Post
taylor.post@terrapinn.com
t/ +1 646 619 1785